{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:26:14Z","timestamp":1791930374923,"version":"4.3.4"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Chronic hypertension and preeclampsia are leading risk enhancers for maternal-neonatal morbidity and mortality. Severe maternal morbidity (SMM) indicators include heart, kidney, and liver disease, but studies have not excluded patients with preexisting diseases that define SMM. Thus, SMM risks for uncomplicated chronic hypertension specific to preeclampsia remain unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine SMM rates and estimate relative risks associated with hypertensive disorders of pregnancy among patients with and without chronic hypertension unencumbered by preexisting vascular or end organ diseases.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study used longitudinal health data from electronic health records from patients within a community-based, integrated health care system in northern California. The study cohort selected 263\u202f518 pregnant patients without pregestational heart, kidney, or liver disease entering prenatal care at 14 weeks\u2019 gestation or earlier and delivering a singleton stillbirth or live birth in 2009 to 2019. The data were analyzed between February 2022 and March 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Five joint subgroups combining chronic hypertension status and the hypertensive disorders developing during pregnancy, defined as follows: (1) chronic hypertension with superimposed preeclampsia, (2) chronic hypertension and no preeclampsia, (3) no chronic hypertension with preeclampsia, (4) gestational hypertension, and (5) no chronic hypertension and no preeclampsia or gestational hypertension (reference group).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcome was SMM rates at delivery hospitalization (cases per 10\u202f000 births) using the Centers for Disease Control and Prevention criteria (\u22651 of 21 indicators to define SMM) obtained from electronic health records. Modified Poisson regression models estimated crude and adjusted relative risks (aRRs) and 95% CIs of SMM associated with the chronic hypertension and developing hypertensive disorders of pregnancy groups vs the reference group (no chronic hypertension and no preeclampsia or gestational hypertension) adjusted for clinical, sociodemographic, social, and behavioral covariates.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The analysis included a total of 263\u202f518 pregnant patients (mean [SD] age at delivery, 31.0 [5.3] years), including 249\u202f892 patients without chronic hypertension (4.7% developed preeclampsia) and 13\u202f626 patients with chronic hypertension (31.5% developed superimposed preeclampsia). The highest SMM rates occurred in the no chronic hypertension with preeclampsia (934.3 [95% CI, 882.3-988.3] cases per 10\u202f000 births) and the chronic hypertension with superimposed preeclampsia (898.3 [95% CI, 814.5-987.8] cases per 10,000 births) groups. Lower SMM rates occurred in the chronic hypertension and no preeclampsia (195.1 [95% CI, 168.0-225.2] cases per 10,000 births), gestational hypertension (312.7 [95% CI, 281.6-346.1] cases per 10,000 births), and no chronic hypertension and no preeclampsia or gestational hypertension (165.8 [95% CI, 160.6-171.2] cases per 10,000 births) groups\n (P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Compared with the no chronic hypertension and no preeclampsia or gestational hypertension group, risks of SMM were significantly higher for the chronic hypertension with superimposed preeclampsia group (aRR, 4.97 [95% CI, 4.46-5.54]), no chronic hypertension with preeclampsia group (aRR, 5.12 [95% CI, 4.79-5.48]), chronic hypertension and no preeclampsia group (aRR, 1.17 [95% CI, 1.003-1.36];\n P<\/jats:italic>\n \u2009=\u2009.046), and the gestational hypertension group (aRR, 1.78 [95% CI 1.60-1.99]).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cohort study found that the highest SMM rates at delivery hospitalization occurred for preeclampsia superimposed on chronic hypertension and preeclampsia without chronic hypertension, while gestational hypertension had intermediate rates of SMM. The patients with chronic hypertension who did not develop preeclampsia had SMM rates that were nearly the same as the lowest-risk patients without chronic hypertension who did not develop preeclampsia or gestational hypertension. These findings provide evidence that prevention of preeclampsia among patients with uncomplicated chronic hypertension is paramount to mitigating maternal morbidity.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.51406","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:00:54Z","timestamp":1738062054000},"page":"e2451406","source":"Crossref","is-referenced-by-count":21,"title":["Severe Maternal Morbidity Associated With Chronic Hypertension, Preeclampsia, and Gestational Hypertension"],"prefix":"10.1001","volume":"8","author":[{"given":"Erica P.","family":"Gunderson","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"},{"name":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, Oakland Medical Center, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Najem","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyang","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E.","family":"Alexeeff","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai N.","family":"Nguyen-Huynh","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"},{"name":"Department of Neurology, Kaiser Permanente, Walnut Creek Medical Center, Walnut Creek, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, Epidemiology and Clinical and Translational Research, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"2","key":"zoi241425r1","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association.","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"issue":"5","key":"zoi241425r2","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1161\/HYPERTENSIONAHA.121.17661","article-title":"Historical and recent changes in maternal mortality due to hypertensive disorders in the United States, 1979 to 2018.","volume":"78","author":"Ananth","year":"2021","journal-title":"Hypertension"},{"issue":"18","key":"zoi241425r3","doi-asserted-by":"publisher","first-page":"e902","DOI":"10.1161\/CIR.0000000000000961","article-title":"Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association.","volume":"143","author":"Parikh","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"zoi241425r4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.119.12968","article-title":"Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010.","volume":"74","author":"Ananth","year":"2019","journal-title":"Hypertension"},{"key":"zoi241425r5","doi-asserted-by":"publisher","DOI":"10.5888\/pcd16.190105","article-title":"Hypertension and diabetes in non-pregnant women of reproductive age in the United States.","volume":"16","author":"Azeez","year":"2019","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"zoi241425r6","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG practice bulletin No. 203: chronic hypertension in pregnancy.","volume":"133","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"zoi241425r7","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin No. 222.","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"11","key":"zoi241425r8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.003904","article-title":"Chronic hypertension in pregnancy.","volume":"129","author":"Seely","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"zoi241425r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.17641","article-title":"Trends in maternal mortality and severe maternal morbidity during delivery-related hospitalizations in the United States, 2008 to 2021.","volume":"6","author":"Fink","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi241425r10","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/aje\/kwab077","article-title":"Severe maternal morbidity: a comparison of definitions and data sources.","volume":"190","author":"Snowden","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"7","key":"zoi241425r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22966","article-title":"Trends in severe maternal morbidity in the US across the transition to ICD-10-CM\/PCS from 2012-2019.","volume":"5","author":"Hirai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi241425r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36148","article-title":"Assessment of incidence and factors associated with severe maternal morbidity after delivery discharge among women in the US.","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"18","key":"zoi241425r14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/jama.2017.16191","article-title":"Association between prepregnancy body mass index and severe maternal morbidity.","volume":"318","author":"Lisonkova","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"zoi241425r15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/AOG.0000000000004057","article-title":"Associations between comorbidities and severe maternal morbidity.","volume":"136","author":"Brown","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi241425r16","doi-asserted-by":"publisher","first-page":"405.e1","DOI":"10.1016\/j.ajog.2018.07.002","article-title":"Contribution of hypertension to severe maternal morbidity.","volume":"219","author":"Hitti","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi241425r17","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/AOG.0000000000005342","article-title":"Chronic hypertension in pregnancy and racial-ethnic disparities in complications.","volume":"142","author":"Leonard","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"11","key":"zoi241425r18","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.7326\/M19-3253","article-title":"Association of maternal comorbidity with severe maternal morbidity: a cohort study of California mothers delivering between 1997 and 2014.","volume":"173","author":"Main","year":"2020","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi241425r19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1055\/a-1886-5404","article-title":"The association of race and ethnicity with severe maternal morbidity among individuals diagnosed with hypertensive disorders of pregnancy.","volume":"40","author":"Palatnik","year":"2023","journal-title":"Am J Perinatol"},{"issue":"3","key":"zoi241425r20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.121.18568","article-title":"Early pregnancy blood pressure patterns identify risk of hypertensive disorders of pregnancy among racial and ethnic groups.","volume":"79","author":"Gunderson","year":"2022","journal-title":"Hypertension"},{"issue":"15","key":"zoi241425r21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029617","article-title":"Early pregnancy systolic blood pressure patterns predict early- and later-onset preeclampsia and gestational hypertension among ostensibly low-to-moderate risk groups.","volume":"12","author":"Gunderson","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"zoi241425r22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2215\/CJN.12591117","article-title":"Acute kidney injury and risk of heart failure and atherosclerotic events.","volume":"13","author":"Go","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"zoi241425r23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy.","volume":"122","author":"American College of Obstetricians Gynecologists, Task Force on Hypertension in Pregnancy","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2S","key":"zoi241425r24","doi-asserted-by":"publisher","first-page":"S1182","DOI":"10.1016\/j.ajog.2020.11.029","article-title":"Chronic hypertension and superimposed preeclampsia: screening and diagnosis.","volume":"226","author":"Kametas","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"zoi241425r26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals.","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"issue":"Suppl 2","key":"zoi241425r27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/00333549141291S206","article-title":"The social determinants of health: it\u2019s time to consider the causes of the causes.","volume":"129","author":"Braveman","year":"2014","journal-title":"Public Health Rep"},{"issue":"7","key":"zoi241425r28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"5","key":"zoi241425r29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/EDE.0000000000000121","article-title":"A unification of mediation and interaction: a 4-way decomposition.","volume":"25","author":"VanderWeele","year":"2014","journal-title":"Epidemiology"},{"issue":"5","key":"zoi241425r30","doi-asserted-by":"publisher","first-page":"435.e1","DOI":"10.1016\/j.ajog.2013.11.039","article-title":"Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008-2010.","volume":"210","author":"Creanga","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"zoi241425r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.36478","article-title":"Hypertensive disorders and cardiovascular severe maternal morbidity in the US, 2015-2019.","volume":"7","author":"Malham\u00e9","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"S 01","key":"zoi241425r32","doi-asserted-by":"publisher","first-page":"e728","DOI":"10.1055\/s-0042-1757354","article-title":"Antihypertensive medication use before and during pregnancy and the risk of severe maternal morbidity in individuals with prepregnancy hypertension.","volume":"41","author":"Bane","year":"2024","journal-title":"Am J Perinatol"},{"issue":"3","key":"zoi241425r33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajog.2023.04.023","article-title":"Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up.","volume":"229","author":"Roberts","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zoi241425r34","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/AOG.0000000000004806","article-title":"Distinguishing high-performing from low-performing hospitals for severe maternal morbidity: a focus on quality and equity.","volume":"139","author":"Howell","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi241425r35","doi-asserted-by":"publisher","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"zoi241425r36","doi-asserted-by":"publisher","first-page":"B7","DOI":"10.1016\/j.ajog.2020.06.003","article-title":"Society for Maternal-Fetal Medicine special statement: checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin.","volume":"223","author":"Combs","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"zoi241425r37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jama.2023.16991","article-title":"Screening for hypertensive disorders of pregnancy: US Preventive Services Task Force final recommendation statement.","volume":"330","author":"Barry","year":"2023","journal-title":"JAMA"},{"issue":"2S","key":"zoi241425r38","doi-asserted-by":"publisher","first-page":"S1102","DOI":"10.1016\/j.ajog.2020.10.047","article-title":"The prediction of preeclampsia: the way forward.","volume":"226","author":"Myatt","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"15","key":"zoi241425r39","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/CIR.0000000000001000","article-title":"Call to action: maternal health and saving mothers: a policy statement from the American Heart Association.","volume":"144","author":"Mehta","year":"2021","journal-title":"Circulation"},{"key":"zoi241425r12","unstructured":"US Department of Health & Human Services. How does CDC identify severe maternal morbidity? Accessed April 1, 2024. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe-morbidity-ICD.htm#print"},{"key":"zoi241425r25","unstructured":"United States Census Bureau. American Community Survey (ACS). Accessed April 1, 2024. https:\/\/www.census.gov\/programs-surveys\/acs\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2829664\/gunderson_2025_oi_241425_1737490246.70927.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:00:58Z","timestamp":1738062058000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2829664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.51406","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]}}}